###begin article-title 0
Regulation of BMAL1 Protein Stability and Circadian Function by GSK3beta-Mediated Phosphorylation
###end article-title 0
###begin p 1
Conceived and designed the experiments: SS LZ EB PSC. Performed the experiments: SS LZ CK. Analyzed the data: SS LZ EB PSC. Contributed reagents/materials/analysis tools: SS. Wrote the paper: SS PSC.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Circadian rhythms govern a large array of physiological and metabolic functions. To achieve plasticity in circadian regulation, proteins constituting the molecular clock machinery undergo various post-translational modifications (PTMs), which influence their activity and intracellular localization. The core clock protein BMAL1 undergoes several PTMs. Here we report that the Akt-GSK3beta signaling pathway regulates BMAL1 protein stability and activity.
###end p 3
###begin title 4
Principal Findings
###end title 4
###begin p 5
###xml 350 357 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
GSK3beta phosphorylates BMAL1 specifically on Ser 17 and Thr 21 and primes it for ubiquitylation. In the absence of GSK3beta-mediated phosphorylation, BMAL1 becomes stabilized and BMAL1 dependent circadian gene expression is dampened. Dopamine D2 receptor mediated signaling, known to control the Akt-GSK3beta pathway, influences BMAL1 stability and in vivo circadian gene expression in striatal neurons.
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
These findings uncover a previously unknown mechanism of circadian clock control. The GSK3beta kinase phosphorylates BMAL1, an event that controls the stability of the protein and the amplitude of circadian oscillation. BMAL1 phosphorylation appears to be an important regulatory step in maintaining the robustness of the circadian clock.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 26 36 26 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">circa diem</italic>
###xml 318 321 318 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Sahar1">[1]</xref>
###xml 323 326 323 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Wijnen1">[2]</xref>
Circadian (from the Latin circa diem meaning "about a day") rhythms occur with a periodicity of about 24 hours and enable organisms to adapt and anticipate environmental changes. Circadian control provides an evolutionary advantage to organisms in adapting their behavior and physiology to the appropriate time of day [1], [2]. Feeding behavior, sleep-wake cycles, hormonal levels and body temperature are just a few examples of physiological circadian rhythms.
###end p 9
###begin p 10
###xml 437 442 437 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cry 1</italic>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cry2</italic>
###xml 468 472 468 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Per1</italic>
###xml 474 478 474 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Per2</italic>
###xml 480 484 480 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Per3</italic>
###xml 757 760 757 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Sahar1">[1]</xref>
From a molecular standpoint, circadian rhythms are regulated by transcriptional and post-translational feedback loops generated by a set of interplaying clock proteins. The positive limb of the mammalian clock machinery is comprised of CLOCK and BMAL1, which are transcription factors that heterodimerize through the PAS domain and induce the expression of clock-controlled genes by binding to their promoters at E-boxes. Cryptochromes (Cry 1, Cry2) and Period genes (Per1, Per2, Per3) are clock-controlled genes that encode proteins that form the negative limb of the circadian machinery. PER and CRY proteins are classically thought to translocate into the nucleus to inhibit CLOCK:BMAL1 mediated transcription, thereby closing the negative feedback loop [1].
###end p 10
###begin p 11
###xml 429 432 429 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Gallego1">[3]</xref>
###xml 535 538 535 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Sanada1">[4]</xref>
###xml 540 543 540 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Tamaru1">[5]</xref>
###xml 545 548 545 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Eide1">[6]</xref>
###xml 562 565 562 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Hirayama1">[7]</xref>
###xml 579 582 579 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Cardone1">[8]</xref>
###xml 584 587 584 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Lee1">[9]</xref>
###xml 607 611 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Kwon1">[10]</xref>
###xml 975 979 969 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Doble1">[11]</xref>
###xml 1100 1104 1091 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Woodgett1">[12]</xref>
###xml 1106 1110 1097 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-MacAulay1">[13]</xref>
###xml 1112 1116 1103 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Wang1">[14]</xref>
###xml 1118 1122 1109 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Jope1">[15]</xref>
Various core clock proteins undergo post-translational modifications (PTMs), a feature that is likely to contribute significantly to the plasticity of the circadian system. PTMs have been shown to regulate distinct functions, including transcriptional activation and intracellular localization. PTMs have been proposed to participate in controlling the timing between the activation and the repression of circadian transcription [3]. Among the clock proteins, BMAL1 undergoes an extensive repertoire of PTMs, including phosphorylation [4], [5], [6], acetylation [7], sumoylation [8], [9] and ubiquitylation [10]. Yet, the signaling pathways controlling the stability of the BMAL1 protein have not been deciphered. In the present study we have identified GSK3beta as a critical regulator of BMAL1 stability and activity. GSK3beta is a ubiquitous kinase which regulates various cellular functions, ranging from glucose homeostasis, to cell survival and cell-fate specification [11]. GSK3beta has been linked to various pathological conditions such as diabetes, Alzheimer's, cancer and bipolar disorder [12], [13], [14], [15].
###end p 11
###begin p 12
###xml 114 120 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">shaggy</italic>
###xml 122 125 119 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sgg</italic>
###xml 132 142 129 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 313 317 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Martinek1">[16]</xref>
###xml 319 323 316 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Cyran1">[17]</xref>
###xml 464 468 458 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Hirota1">[18]</xref>
###xml 744 748 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Iitaka1">[19]</xref>
###xml 923 927 904 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Harada1">[20]</xref>
###xml 966 970 943 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Yin1">[21]</xref>
###xml 132 142 <span type="species:ncbi:7227">Drosophila</span>
The role of GSK3beta in circadian control has been reported. The first evidence was based on the observation that shaggy (sgg), the Drosophila ortholog of GSK3, controls the period of circadian locomotor activity by phosphorylating TIMELESS and regulating nuclear translocation of the PERIOD/TIMELESS heterodimer [16], [17]. Recently a high-throughput approach demonstrated that inhibition of GSK3beta leads to shortening of the period in cultured mammalian cells [18]. In mammals, GSK3beta has been reported to phosphorylate PER2, CRY2 and Rev-erbalpha. It has also been reported that the kinase activity of GSK3beta oscillates in the central mammalian clock, suprachiasmatic nucleus (SCN) and in the peripheral clocks (liver and fibroblasts) [19]. GSK3beta mediated phosphorylation appears to have differential effect on the stability of the targeted substrates, since it has been shown to induce the degradation of CRY2 [20] and the stabilization of Rev-erbalpha [21]. Here we show that GSK3beta specifically phosphorylates BMAL1 and primes it for ubiquitylation, followed by proteasomal degradation. This control mechanism significantly influences the efficacy and amplitude of circadian gene expression.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
GSK3beta Phosphorylates BMAL1 and Primes It for Ubiquitylation
###end title 14
###begin p 15
###xml 54 57 54 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Sanada1">[4]</xref>
###xml 59 62 59 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Tamaru1">[5]</xref>
###xml 64 67 64 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Eide1">[6]</xref>
###xml 260 268 254 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 395 397 382 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 597 604 581 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g001">Fig. 1A</xref>
###xml 1016 1023 985 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g001">Fig. 1B</xref>
BMAL1 is a phosphoprotein targeted by various kinases [4], [5], [6]. We noted that BMAL1 contains 15 sites with the consensus T/SXXXS/T phosphoacceptor sequence for GSK3beta. This prompted us to determine whether GSK3beta can phosphorylate BMAL1. We performed in vitro kinase assays on bacterially purified GST-BMAL1 or GST alone by incubating them with recombinant GSK3beta in presence of gamma32P-ATP. Our results demonstrate that GST-BMAL1 was readily phosphorylated by GSK3beta, whereas GST alone, although expressed at much greater levels, was not phosphorylated under equivalent conditions (Fig. 1A). Thus, BMAL1 appears to be an efficient substrate of GSK3beta. Furthermore, to detect physical association between BMAL1 and GSK3beta, HEK 293 cells were transiently transfected with plasmids expressing BMAL1 and CLOCK in the presence or absence of GSK3beta. Immunoprecipitation of BMAL1, either in presence or absence of CLOCK, pulled down GSK3beta, confirming that BMAL1 and GSK3beta do interact physically (Fig. 1B).
###end p 15
###begin title 16
GSK3beta phosphorylates BMAL1 and primes it for ubiquitylation.
###end title 16
###begin p 17
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 127 129 120 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
(A) In vitro Kinase assay. Bacterially purified GST and GST-BMAL1 were incubated with recombinant GSK3beta in presence of gamma32P-ATP. Top panel shows the autoradiogram; bottom panel shows the coomassie blue staining for the same gel. (B) HEK 293 cells were transfected with plasmids expressing Flag-myc-BMAL1, myc-CLOCK with or without HA-GSK3beta. Total lysates were prepared and subjected to immunoprecipitation using anti-BMAL1 antibody. Immunoprecipitated proteins were detected by Western blotting (WB) using indicated antibodies. (C) Ubiquitylation assay. HEK 293 cells were transfected with plasmids expressing HIS-Ubiquitin, Flag-myc-BMAL1, myc-CLOCK, with or without the constitutively active (CA) or kinase dead (KD) mutants of HA- tagged GSK3beta. Ubiquitylated BMAL1 was detected by Western analysis using anti-Flag antibody. Input samples were probed with anti-Flag (to detect BMAL1) and anti-GSK3beta antibodies.
###end p 17
###begin p 18
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Yagita1">[22]</xref>
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Virshup1">[23]</xref>
###xml 278 282 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Hart1">[24]</xref>
###xml 284 288 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Wu1">[25]</xref>
###xml 290 294 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Guo1">[26]</xref>
###xml 943 950 925 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g001">Fig. 1C</xref>
Control of clock protein stability is a key regulatory step to insure the tightness of circadian rhythms [22], [23]. Moreover, it has been shown that GSK3beta-mediated phosphorylation of beta-catenin, SRC-3, and Smad3 leads to ubiquitylation followed by proteosomal degradation [24], [25], [26]. Hence, we addressed the question of whether GSK3beta affects BMAL1 ubiquitylation. We co-expressed HIS-tagged ubiquitin along with Myc-CLOCK and Flag-Myc-BMAL1 with or without constitutively active (CA, Ser9>Ala mutation) or kinase dead (KD, Lys85>Ala) mutants of HA-tagged GSK3beta. Ubiquitylated proteins were pulled down using Ni-Sepharose beads under denaturing conditions and resolved by SDS-PAGE. Upon Western analysis using anti-Flag antibody to specifically detect BMAL1, we observed that co-expression of CA-GSK3beta greatly enhanced BMAL1 ubiquitylation, whereas co-expression of KD-GSK3beta had no effect on basal BMAL1 ubiquitylation (Fig. 1C). This result confirmed that phosphorylation by GSK3beta primes BMAL1 for ubiquitylation. Thus, phosphorylation by GSK3beta appears to be an important step in BMAL1 proteosomal degradation, controlling BMAL1 cyclic protein levels.
###end p 18
###begin title 19
Inhibition of GSK3beta Activity Enhances BMAL1 Stability
###end title 19
###begin p 20
###xml 211 215 202 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Beaulieu1">[27]</xref>
###xml 529 536 517 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g002">Fig. 2A</xref>
###xml 653 660 641 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g002">Fig. 2A</xref>
To further prove that phosphorylation by GSK3beta affects BMAL1 stability, we sought to inhibit GSK3beta activity. Activation of the Akt kinase results in phosphorylation and consequent inactivation of GSK3beta [27]. We transiently co-expressed BMAL1 and CLOCK, in presence or absence of a myristoylated form of Akt that turns this kinase in a constitutively active status (CA-Akt). Western analyses confirmed that co-expression of CA-Akt indeed caused an increase in phosphorylation of GSK3beta and its consequent inactivation (Fig. 2A). Interestingly, expression levels of BMAL1, but not CLOCK, was highly induced in cells that also expressed CA-Akt (Fig. 2A). These results support the notion that phosphorylation by GSK3beta might lead to BMAL1 degradation.
###end p 20
###begin title 21
GSK3beta regulates BMAL1 stability.
###end title 21
###begin p 22
###xml 397 400 391 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 805 808 790 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
(A) HEK 293 cells were co-transfected with plasmids expressing Flag-myc-BMAL1, myc-CLOCK with or without CA-Akt. 48 hours post-transfection nuclear lysates were prepared and resolved by SDS-PAGE. CLOCK and BMAL1 levels were detected by Western analysis using anti-Myc antibody; phospho- and total GSK3beta and HSC70 (loading control) were detected by using specific antibodies. (B) WT and GSK3beta-/- MEFs were transfected with plasmids expressing Flag-myc-BMAL1, myc-CLOCK and myc-GFP. Nuclear lysates were resolved by SDS-PAGE followed by Western analysis. BMAL1 and GFP levels were detected by anti-Myc antibody. Total GSK3beta was detected using a specific antibody. (C) Same as in (B) except that indicated lanes were also transfected with a plasmid expressing HA-tagged GSK3beta. (D) WT and GSK3beta-/- MEFs were treated with 50 microg/ml Cycloheximide (CHX), total lysates were prepared at indicated times and resolved by SDS-PAGE. Endogenous BMAL1 and GAPDH levels were detected by Western analysis using specific antibodies. Data shown is representative of three independent experiments.
###end p 22
###begin p 23
###xml 133 136 130 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 247 250 241 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 280 287 274 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g002">Fig. 2B</xref>
###xml 483 486 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 598 601 580 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 698 701 671 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 785 792 758 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g002">Fig. 2C</xref>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
To further substantiate our hypothesis, we ectopically expressed BMAL1 in mouse embryo fibroblasts (MEFs) derived from WT or GSK3beta-/- mice. Myc-tagged GFP was co-expressed as a control. We observed that BMAL1 levels were much higher in GSK3beta-/- MEFs as compared to WT MEFs (Fig. 2B). GFP levels were similar in both cell lines. These results demonstrate that there is significantly higher accumulation of BMAL1 in the absence of GSK3beta. Next, we sought to rescue the GSK3beta-/- MEFs by re-introducing GSK3beta. BMAL1 was ectopically expressed by transient transfection into WT and GSK3beta-/- MEFs, in conjunction or not of a HA-tagged GSK3beta. Rescue of GSK3beta function in the GSK3beta-/- MEFs caused a decrease in BMAL1 protein levels which returned to those in WT MEFs (Fig. 2C).
###end p 23
###begin p 24
###xml 114 117 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 277 284 268 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g002">Fig. 2D</xref>
To determine whether the half-life of the endogenous BMAL1 protein depends on GSK3beta, we treated WT and GSK3beta-/- MEFs with cycloheximide to block protein synthesis. Importantly, both BMAL1 basal protein levels and its stability are much higher in the absence of GSK3beta (Fig. 2D). These results show that phosphorylation of BMAL1 by GSK3beta regulates its stability.
###end p 24
###begin title 25
S17 and T21 on BMAL1 Are Targets for GSK3beta Mediated Phosphorylation
###end title 25
###begin p 26
###xml 287 296 281 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g003">Fig. 3A,B</xref>
###xml 622 631 610 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bona fide</italic>
###xml 1239 1246 1224 1231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g003">Fig. 3C</xref>
Among the 15 consensus GSK3beta sites on BMAL1, we focused our attention on two loci which contained multiple GSK3beta consensus sites in tandem. These sites included a region between residues 9 and 25, and another between residues 233 and 241 which are highly conserved in vertebrates (Fig. 3A,B). Importantly, both loci contain a motif which fits a highly stringent consensus for GSK3beta mediated phosphorylation [S/TPXXS/T]. Thus, S17 and T21 at the first locus, and T233 and S237 at the second locus, appear to be privileged candidates for phosphorylation by GSK3beta. In order to determine if any of these sites are bona fide targets for GSK3beta, we first analyzed the effect of point mutations at these sites on BMAL1 phosphorylation. We generated a panel of Ser>Ala mutants including: (i) S17 and T21 (S17,T21/A), (ii) T233, S237 and S241 (T233,S237,S241/A), and (iii) S17, T21, T233, S237 and S241 (S17,T21,T233,S237,S241/A). Plasmids expressing either wild type or BMAL1 mutants were co-transfected in HEK 293 cells along with a plasmid expressing Myc-CLOCK and harvested 48 hours post-transfection. Although phosphorylation was reduced in all mutants, mutation of S17 and T21 caused maximal reduction in BMAL1 phosphorylation (Fig. 3C).
###end p 26
###begin title 27
GSK3beta phosphorylates Ser 17 and Thr 21 on BMAL1.
###end title 27
###begin p 28
###xml 591 599 585 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 620 627 614 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g001">Fig. 1A</xref>
###xml 1128 1135 1118 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g003">Fig. 3E</xref>
(A) Amino acid sequence around two putative GSK3beta consensus sites on mBMAL1. (B) Sequence alignment of the two putative GSK3beta consensus sites on BMAL1 showing conservation across species. (C) HEK 293 were transfected with plasmids expressing myc-CLOCK and WT or mutant Flag-myc-BMAL1. 48 hours post-transfection total lysates were prepared and resolved by SDS-PAGE. BMAL1 and CLOCK levels were detected by anti-Myc antibody. Slower migrating phosphorylated BMAL1 band is indicated by an arrow. (D) Bar graph representing phosphorylation levels of WT and S17,T21/A BMAL1 as analyzed by In vitro kinase assay (as in Fig. 1A). Data is representative of three independent experiments. (E) WT or S17,T21/A mutant of Flag-myc-BMAL1, along with myc-GFP were transiently expressed in JEG3 cells and treated with 50 microg/ml CHX. Total lysates were prepared at indicated times and resolved by SDS-PAGE. BMAL1 and GFP levels were detected by Western analysis using anti-myc antibody. Data shown is representative of three independent experiments. (F) Line graph showing quantitation of BMAL1 levels, normalized to GFP levels, from Fig. 3E.
###end p 28
###begin p 29
###xml 83 91 80 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 247 254 241 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g003">Fig. 3D</xref>
###xml 612 621 603 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g003">Fig. 3E,F</xref>
To prove that S17 and T21 are directly phosphorylated by GSK3beta, we performed an in vitro kinase assay with WT and mutant forms of GST-BMAL1. We observed that GSK3beta mediated phosphorylation of BMAL1 was reduced when S17 and T21 were mutated (Fig. 3D). This result shows that S17 and T21 are critical sites of GSK3beta-mediated phosphorylation, and indicates the presence of yet unrecognized phosphoacceptor sites in the protein. Interestingly, the importance of the S17,T21 sites is validated by the higher, albeit modest, stability of the S17,T21A-BMAL1 mutated protein as compared to the wild type BMAL1 (Fig. 3E,F).
###end p 29
###begin title 30
Oscillation in GSK3beta Activity Correlates with BMAL1 Levels
###end title 30
###begin p 31
###xml 206 209 197 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 409 416 400 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g004">Fig. 4A</xref>
###xml 443 446 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 556 563 544 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g004">Fig. 4A</xref>
###xml 583 588 571 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmal1</italic>
###xml 667 670 652 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 701 708 686 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g004">Fig. 4B</xref>
###xml 898 901 877 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Our results show that GSK3beta regulates BMAL1 levels. Thus, we questioned whether BMAL1 oscillation would be influenced in the absence of GSK3beta. To address this question, we synchronized WT and GSK3beta-/- MEFs, and analyzed BMAL1 levels by Western analysis. BMAL1 levels oscillate as expected in WT MEFs, peaking at 6 to 12 hours post-synchronization with lowest levels at 24 hours post-synchronization (Fig. 4A). BMAL1 levels in GSK3beta-/- MEFs display only a mild oscillation, with total levels of the protein being much higher at all time points (Fig. 4A). Importantly, the Bmal1 transcript levels and cyclic expression profile were unchanged in the GSK3beta-/- MEFs as compared to WT cells (Fig. 4B). These results indicate that GSK3beta is critical for the circadian oscillation of BMAL1 protein. It is, however, important to stress that the residual oscillation of BMAL1 in the GSK3beta-/- MEFs indicates the presence of other pathways which may contribute to BMAL1 turnover. One pathway could implicate GSK3alpha, a kinase structurally similar to GSK3beta but not as comprehensively studied.
###end p 31
###begin title 32
###xml 29 32 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Circadian defects in GSK3beta-/- MEFs.
###end title 32
###begin p 33
###xml 15 18 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 402 407 395 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmal1</italic>
###xml 464 469 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmal1</italic>
###xml 720 723 703 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dbp</italic>
###xml 780 783 763 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dbp</italic>
WT and GSK3beta-/- MEFs were synchronized by 2 hour treatment with 100nM dexamethasone (DEX). (A) Total lysates were prepared at indicated times post synchronization and resolved by SDS-PAGE followed by Western analysis. BMAL1 and alpha-tubulin levels were detected by specific antibodies. (B) RNA was prepared at indicated times, reverse transcribed, and real-time PCR was performed using primers for Bmal1 and 18S rRNA. Data is represented as relative levels of Bmal1 normalized to 18S rRNA. (C) Same as in (A), except phospho-GSK3alpha/beta and total GSK3beta levels were detected by specific antibodies. (D) RNA was prepared at indicated times, reverse transcribed, and real-time PCR was performed using primers for Dbp and 18S rRNA. Data is represented as relative levels of Dbp normalized to 18S rRNA.
###end p 33
###begin p 34
###xml 305 312 296 303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g004">Fig. 4C</xref>
###xml 510 519 495 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g004">Fig. 4A,C</xref>
Next we analyzed whether regulation of GSK3beta activity by phosphorylation may oscillate in a circadian manner. Using anti phospho-GSK3beta antibodies we reveal that there is more phosphorylation of GSK3beta (corresponding to decreased kinase activity) at 6 to 12 hours post synchronization of the MEFs (Fig. 4C). The peak of GSK3beta phosphorylation correlates with the increase in BMAL1 protein levels; vice versa, when GSK3beta activity is high (24 to 30 hours post synchronization), BMAL1 levels are low (Fig. 4A,C).
###end p 34
###begin p 35
###xml 123 130 116 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g004">Fig. 4C</xref>
###xml 243 246 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
As it is not known whether GSK3alpha activity may be circadian, we analyzed its phosphorylation in parallel with GSK3beta (Fig. 4C). GSK3alpha phosphorylation oscillates with a profile analogous to GSK3beta, an event that persisted in GSK3beta-/- MEFs. This observation may suggest that GSK3alpha could partially compensate for the loss of GSK3beta in circadian control, although more studies are needed to confirm whether GSK3alpha plays a role in BMAL1 phosphorylation and turnover.
###end p 35
###begin title 36
###xml 8 11 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 59 62 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dbp</italic>
GSK3beta-/- MEFs Display Dampened Circadian Oscillation of Dbp mRNA
###end title 36
###begin p 37
###xml 179 182 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dbp</italic>
###xml 206 209 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 302 305 293 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dbp</italic>
###xml 396 403 387 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g004">Fig. 4D</xref>
###xml 546 550 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Muratani1">[28]</xref>
The regulation of BMAL1 phosphorylation and stability by GSK3beta may impact on the cyclic expression of clock-controlled genes. We thereby compared the expression profile of the Dbp gene in WT and GSK3beta-/- MEFs synchronized by dexamethasone. Lack of GSK3beta resulted in a significant dampening of Dbp oscillation as compared to WT MEFs, featuring a conserved period but decreased amplitude (Fig. 4D). These results support the notion that stabilization of BMAL1 protein levels might lead to reduction in its transcription activation ability [28].
###end p 37
###begin title 38
Dopamine Signaling Regulates the Circadian Clock by Controlling BMAL1 Turnover
###end title 38
###begin p 39
###xml 104 111 101 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 111 115 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Beaulieu2">[29]</xref>
###xml 252 256 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Yujnovsky1">[30]</xref>
###xml 278 281 275 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 287 291 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Baik1">[31]</xref>
###xml 362 369 356 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 545 550 539 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmal1</italic>
###xml 595 598 589 592 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 608 615 602 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g005">Fig. 5A</xref>
###xml 670 673 664 667 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 680 687 674 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g005">Fig. 5B</xref>
###xml 780 786 771 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g004">Fig. 4</xref>
###xml 858 861 846 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 918 921 906 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dbp</italic>
###xml 926 930 914 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Per2</italic>
###xml 980 983 968 971 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 990 1003 978 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g005">Fig. 5C and D</xref>
###xml 1129 1136 1114 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 674 678 <span type="species:ncbi:10090">mice</span>
###xml 984 988 <span type="species:ncbi:10090">mice</span>
Dopamine signaling via the D2 receptor (D2R) has been demonstrated to modulate the Akt-GSK3beta pathway in vivo[29]. In addition, we have previously reported that CLOCK:BMAL1 transcriptional activity is enhanced by activation of D2R-mediated signaling [30]. We thus used the D2R-/- mice [31] as a model to analyze the effect of inactivating the GSK3beta pathway in vivo. To do so, we isolated the striatum from brains of mice entrained at different times of the circadian cycle (LD 12:12). While the cyclic expression profile and mRNA levels of Bmal1 were similar in the striatum from WT and D2R-/- animals (Fig. 5A), the levels of BMAL1 protein were elevated in the D2R-/- mice (Fig. 5B). This result parallels the inactivation of the GSK3beta pathway observed in cultured MEFs (Fig. 4). Also, consistent with the expression profile observed in the GSK3beta-/- MEFs, the amplitude of the circadian expression of both Dbp and Per2 is significantly decreased in the striatum of D2R-/- mice (Fig. 5C and D). These results confirm that the GSK3beta pathway regulates circadian gene expression by controlling BMAL1 protein stability in vivo.
###end p 39
###begin title 40
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
BMAL1 mRNA and protein levels in WT and D2R-/- mice.
###end title 40
###begin p 41
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmal1</italic>
###xml 297 302 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmal1</italic>
###xml 556 559 552 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dbp</italic>
###xml 568 572 564 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Per2</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice entrained in 12 hr Light - 12 hr Dark cycles were sacrificed at indicated times and their striatum was dissected out. (A) RNA was prepared at indicated times, reverse transcribed, and real-time PCR was performed using primers for Bmal1 and 18S rRNA. Data is represented as relative levels of Bmal1 normalized to 18S rRNA. (B) Total lysates were prepared and resolved by SDS-PAGE. BMAL1 and alpha-tubulin levels were detected by Western analysis using specific antibodies. (C,D) Same as in (A), except real-time PCR was performed using primers for (C) Dbp and (D) Per2.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Bunger1">[32]</xref>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Kondratov1">[33]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Shimba1">[34]</xref>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Rudic1">[35]</xref>
###xml 372 377 372 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmal1</italic>
###xml 471 492 471 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">glucose transporter 2</italic>
###xml 494 499 494 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">glut2</italic>
###xml 602 606 602 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Lamia1">[36]</xref>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
###xml 333 337 <span type="species:ncbi:10090">Mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
BMAL1 is a critical regulator of the circadian clock. Its ablation in the mouse, in addition to causing arrhythmicity [32], leads to premature aging and reduced life-span [33]. BMAL1 is a crucial player in the regulation of metabolism, playing a role in adipogenesis [34] and in the control of glucose and triglycerides levels [35]. Mice with a liver specific deletion of Bmal1 show normal locomotor activity, but the circadian expression of key metabolic genes, such as glucose transporter 2 (glut2), is abolished. This results in mice being hypoglycemic during the fasting phase of the feeding cycle [36].
###end p 43
###begin p 44
###xml 161 164 161 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Hirayama1">[7]</xref>
###xml 178 181 178 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Cardone1">[8]</xref>
###xml 183 186 183 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Lee1">[9]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Kwon1">[10]</xref>
###xml 365 369 365 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Kwon1">[10]</xref>
###xml 371 375 371 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Kondratov2">[37]</xref>
###xml 505 508 493 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Eide1">[6]</xref>
###xml 552 555 540 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Sanada1">[4]</xref>
###xml 662 665 646 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Tamaru1">[5]</xref>
The important roles played by BMAL1 parallel multiple levels of regulation of its function. BMAL1 undergoes various PTMs, including phosphorylation, acetylation [7], sumoylation [8], [9] and ubiquitylation [10]. While the functional interactions between these PTMs have not been deciphered, phosphorylation by distinct kinases appears to regulate unique activities [10], [37]. Specifically, phosphorylation by Casein Kinase Iepsilon (CKIepsilon) has been reported to activate BMAL1-mediated transcription [6], while phosphorylation by MAPK inhibits it [4]. Recently we have shown that CK2alpha-mediated phosphorylation regulates BMAL1 intracellular localization [5]. Our present results indicate that GSK3beta activity is circadian and that BMAL1 phosphorylation by this kinase controls its stability.
###end p 44
###begin p 45
###xml 482 492 476 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neurospora</italic>
###xml 550 554 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Baker1">[38]</xref>
###xml 790 794 784 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Vanselow1">[39]</xref>
###xml 1165 1169 1150 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Spengler1">[40]</xref>
###xml 1264 1270 1249 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g005">Fig. 5</xref>
###xml 1366 1370 1348 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Jope1">[15]</xref>
###xml 2120 2126 2092 2098 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g004">Fig. 4</xref>
Our analysis identified S17 and T21 in BMAL1 as major target sites for GSK3beta- mediated phosphorylation. While mutation of these residues leads to a reduction of phosphorylation and an increase in BMAL1 stability, we predict the presence of additional GSK3beta phosphoacceptor sites on BMAL1. Importantly, multiple phosphorylation events on a clock protein, presumably by multiple kinases appear to be a common mode of regulation. For example, it has been recently shown that the Neurospora clock protein FREQUENCY is phosphorylated at 75 residues [38]. The phosphorylation status of several of these residues changes according to the time of the day and regulates period length. In mammals, PER2 has been shown to be phosphorylated at 21 sites, regulating its stability and localization [39]. While a detailed proteomic analysis of BMAL1 phosphorylation is warranted, our results reveal that GSK3beta is pivotal in circadian function as it controls the stability of a core clock regulator. Further illustrating the importance of GSK3beta in circadian regulation, a recent report demonstrated that GSK3beta can also phosphorylate CLOCK and regulate its stability [40]. It would be interesting to explore whether, similarly to what we describe here for dopamine (Fig. 5), some specific pathways known to operate via GSK3beta, such as the insulin signaling in liver [15], regulate the circadian clock by altering the phosphorylation state and the stability of BMAL1. The implication of GSK3beta in circadian control is significant, especially considering that this kinase has been linked to various diseases such as diabetes, Alzheimer's, cancer and neuropsychiatric disorders. The link between D2R signaling and BMAL1 stability is challenging, as dopamine dysfunctions underlie neurological and psychiatric disorders which are disruptive of the circadian clock. Future studies will determine whether GSK3beta-mediated disruption of normal circadian control is causally linked to some of these pathological conditions. In this sense, it is interesting that the activity of GSK3alpha also oscillates in circadian manner (Fig. 4). Although our data suggests that GSK3alpha might partially compensate for the loss of GSK3beta, further studies are needed to determine whether BMAL1 and other clock components can be phosphorylated by GSK3alpha.
###end p 45
###begin p 46
###xml 172 176 162 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Yin1">[21]</xref>
###xml 224 229 210 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmal1</italic>
###xml 342 347 321 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmal1</italic>
###xml 631 634 600 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 666 673 635 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g002">Fig. 2D</xref>
###xml 807 813 773 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g002">Fig. 2</xref>
###xml 864 869 830 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmal1</italic>
###xml 982 985 941 944 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 998 1001 957 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1054 1059 1013 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmal1</italic>
###xml 1108 1119 1067 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g004">Figs. 4 A,B</xref>
###xml 1124 1129 1083 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008561-g005">5 A,B</xref>
###xml 1002 1006 <span type="species:ncbi:10090">mice</span>
It could be argued that the effects of GSK3beta on BMAL1 are indirect. It has indeed been shown that phosphorylation of Rev-erbalpha by GSK3beta leads to its stabilization [21]. Since Rev-erbalpha is a negative regulator of Bmal1 transcription, it can be expected that when GSK3beta is inhibited, Rev-erbalpha will be less stable, and hence, Bmal1 transcription may be de-repressed. However, our results conclusively demonstrate that the observed stabilization of BMAL1 protein upon GSK3beta inhibition is independent of Rev-erbalpha. The evidence in support of our argument is: (i) BMAL1 protein has a longer half-life in GSK3beta-/- MEFs when compared to WT MEFs (Fig. 2D); (ii) BMAL1 accumulation upon GSK3beta inhibition is evident not only on endogenous BMAL1, but also on ectopically expressed BMAL1 (Fig. 2). The exogenous BMAL1 is not under control of the Bmal1 promoter and hence can not be affected by Rev-erbalpha; and (iii) BMAL1 protein levels are higher in the GSKbeta-/- MEFs and D2R-/- mice than in their wild type counterparts, although Bmal1 circadian mRNA levels are virtually equivalent (Figs. 4 A,B and 5 A,B). Altogether, the present findings unequivocally show that phosphorylation of BMAL1 by GSK3beta is a critical step in the control of its stability.
###end p 46
###begin p 47
###xml 187 191 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Preitner1">[41]</xref>
###xml 226 231 222 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bmal1</italic>
###xml 231 234 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 240 244 236 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-McDearmon1">[42]</xref>
###xml 375 379 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cry1</italic>
###xml 381 384 377 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Dbp</italic>
###xml 523 526 516 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 539 542 532 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
Recent reports have indicated that although circadian locomotor activity persists in mice displaying constitutively higher levels of BMAL1, either due to abolished Rev-erbalpha expression[41] or by transgenic re-expression in Bmal1-/- mice [42], the period length is rendered shorter. Moreover, robustness in tissue-specific circadian expression of certain clock genes (e.g. Cry1, Dbp) is compromised in these animals. These observations are in agreement with our data showing that increased BMAL1 protein levels in GSKbeta-/- MEFs and D2R-/- mice does not abolish circadian gene expression, but affects its amplitude.
###end p 47
###begin p 48
###xml 84 88 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Hunter1">[43]</xref>
###xml 333 337 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Hunter1">[43]</xref>
###xml 468 472 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Muratani1">[28]</xref>
###xml 739 743 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Salghetti1">[44]</xref>
###xml 1014 1018 1003 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Lee2">[45]</xref>
PTMs are often found in specific combinations in order to regulate protein activity [43]. Phosphorylation and ubiquitylation are often found to be coupled. In certain cases, such as beta-catenin, IkappaBalpha, cyclin E, SREBP1, phosphorylation of a protein generates a "Phosphodegron" which promotes recognition by ubiquitin ligases [43]. Interestingly, in case of some transcription factors, their transcriptional activation domains (TAD) and degrons are overlapping [28]. The "Black Widow" model for transcription activation suggests that certain transcription factors are active only when unstable and their ubiquitylation status positively correlates with their activity. For example, stabilization of VP16 TAD causes its inactivation [44]. The VP16 TAD signals its ubiquitylation through the Met30 ubiquitin ligase. In the absence of Met30, VP16 is more stable but is unable to activate transcription. For BMAL1, it is notable that at specific times of the day when its abundance is low, its activity is high [45]. The low abundance of BMAL1 also coincides with its high phosphorylation. Thus, we speculate that activation by BMAL1 also follows the "Black Widow" model: upon GSK3beta mediated phosphorylation and generation of phosphodegrons, ubiquitylation by yet uncharacterized ubiquitin ligases would de-stabilize and thus, activate BMAL1. Identification of the E3 ubiquitin ligase specific for BMAL1, and the sites for ubiquitylation on BMAL1 should be the subject of future studies that would provide invaluable information on the control of circadian rhythms.
###end p 48
###begin title 49
Materials and Methods
###end title 49
###begin title 50
Animals
###end title 50
###begin p 51
###xml 52 56 52 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Baik1">[31]</xref>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 118 122 <span type="species:ncbi:10090">Mice</span>
###xml 238 242 <span type="species:ncbi:10090">Mice</span>
Generation of D2R-deficient mice has been described [31]. The D2R-null mice and wild type mice used were littermates. Mice housed in individual cages were entrained on a L12:D12 (12 h light-12 h dark) cycle for two weeks before analyses. Mice were sacrificed at specified circadian times and striata were isolated and homogenized as described (27). All research involving vertebrate animals has been performed under protocol approved by the Institutional Animal Care and Use Committee (IACUC). Animals are monitored on a daily basis by both the lab and University Lab Animal Resources (ULAR) veterinary staff for signs of distress, pain, and/or infection, and are given ad libitum access to food and water. Cages were cleaned on a weekly basis and when visibly soiled to maintain a clean environment. All husbandry procedures and welfare policies are conducted according to the Guide for the Care and Use of Laboratory Animals, set forth by the Institute of Laboratory Animal Resources, Commission on Life Sciences, and National Research Council.
###end p 51
###begin title 52
Reagents
###end title 52
###begin p 53
###xml 401 404 398 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008561-Hirayama1">[7]</xref>
Plasmid expressing a myristoylated form of AKT (constitutively active) was from Millipore (Temecula, CA). Plasmids expressing wild type, constitutively active or kinase dead forms of GSK3beta were gifts from Dr. Jim Woodgett (Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada). Myc-tagged Clock, Flag-Myc- tagged Bmal1, and Myc-tagged GFP plasmids have been described earlier [7]. Antibodies against phospho-GSK3alpha/beta were from Cell Signaling Technology (Danvers, MA); anti-Myc and anti-GAPDH from Millipore (Temecula, CA); anti-flag and anti-tubulin from Sigma (St. Louis, MO); anti-HSC70 from Santa Cruz Biotechnology, Inc (Santa Cruz, CA); and anti-total GSK3beta was from BD Biosciences (San Jose, CA). Site directed mutagenesis kit was from Stratagene (La Jolla, CA).
###end p 53
###begin title 54
Cell Culture and Transfection
###end title 54
###begin p 55
###xml 588 591 585 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 359 364 <span type="species:ncbi:10090">Mouse</span>
HEK 293 cells (ATCC, Manassas, VA) were cultured in DMEM supplemented with 10% NCS and antibiotics. JEG3 cells (ATCC, Manassas, VA) were cultured in BME supplemented with 10% FBS and antibiotics. Cells were transfected with indicated plasmids using BioT transfection reagent (Bioland Scientific LLC, Cerritos, CA) according to manufacturer's recommendations. Mouse embryonic fibroblasts (MEFs) were cultured in DMEM supplemented with 10% FBS and antibiotics. Confluent MEFs were synchronized by treatment with 100nM Dexamethasone (Sigma, St. Louis, MO) for 2 hours. Wild type and GSK3beta-/- MEFs were generous gifts from Dr. Jim Woodgett.
###end p 55
###begin title 56
Preparation of Total and Nuclear Extracts from Cultured Cells
###end title 56
###begin p 57
###xml 145 146 145 146 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 392 393 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 610 611 610 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cells were washed twice with cold phosphate buffered saline (PBS) and lysed in RIPA buffer (50 mM Tris pH 8.0, 150 mM NaCl, 5 mM EDTA, 15 mM MgCl2, 1% NP40, 1x protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN ), 1mM DTT, 10 mM NaF, 1 mM PMSF). For nuclear extracts, after washing cells with cold PBS, cells were lysed with hypotonic buffer (10 mM HEPES-KOH pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 1x protease inhibitor cocktail, 1mM DTT, 10 mM NaF, 1 mM PMSF). Following a brief centrifugation, pellet was resuspended in hypertonic buffer (20 mM HEPES-KOH pH 7.9, 25% glycerol, 420 mM NaCl, 1.5mM MgCl2, 0.2 mM EDTA, 1x protease inhibitor cocktail, 1mM DTT, 10 mM NaF, 1 mM PMSF). Supernatants were recovered as nuclear extracts.
###end p 57
###begin title 58
Ubiquitylation Analysis
###end title 58
###begin p 59
HEK 293 cells were co-tranfected with plasmids expressing HIS-tagged ubiquitin, Myc-Clock, flag-Myc-Bmal1 and constitutively active (CA) or kinase dead (KD) mutants of HA-tagged GSK3beta. 48 hours post-transfection, cells were treated with 10 microM MG132 for 6 hours, and then lysed in denaturing buffer containing 8 M Urea. Ubiquitylated (and thus HIS tagged) proteins were enriched with Ni-sepharose 6 fast flow beads (GE healthcare, Uppsala, Sweden) and ubiquitylated BMAL1 was detected by Western analysis with the antibody against Flag.
###end p 59
###begin title 60
In Vitro Kinase Assay
###end title 60
###begin p 61
###xml 88 104 88 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 254 255 254 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 413 415 398 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 88 104 <span type="species:ncbi:562">Escherichia coli</span>
Glutathione-S-transferase (GST) or GST-BMAL1 proteins were purified from BL21 strain of Escherichia coli using glutathione- sepharose beads (GE Healthcare, Uppsala, Sweden). Purified proteins were washed in kinase buffer (20mM Tris-HCl, pH 7.5, 10mM MgCl2, 5mM DTT) and then incubated with or without 25 ng recombinant GSK-3beta (New England Biolabs, Ipswich, MA) in presence of 200 microM ATP and 5 microCi gamma32p ATP at 30degreesC for 30 min. Reaction was terminated by boiling in presence of Laemmli buffer. Samples were resolved by SDS-PAGE, stained by Coomassie blue, destained, dried and then phosphorylated BMAL1 was detected by autoradiography.
###end p 61
###begin title 62
Quantitative Real-Time RT-PCR
###end title 62
###begin p 63
Each quantitative real-time RT-PCR was performed using the Chromo4 real time detection system (BIO-RAD). The PCR primers for mBmal1 mRNA, mDbp mRNA, mPer2 mRNA, 18S rRNA are available upon request. For a 20 microl PCR, 50 ng of cDNA template was mixed with the primers to final concentrations of 200 nM and 10 microl of iQ SYBR Green Supermix (BIO-RAD), respectively. The reaction was first incubated at 95degreesC for 3 min, followed by 40 cycles at 95degreesC for 30 s and 60degreesC for 1 min.
###end p 63
###begin p 64
We would like to thank all the members of the Sassone-Corsi and Borrelli laboratories for reagents and helpful discussions. We thank Dr. Jim Woodgett for providing us valuable reagents and Claudia De Mei for help with striatum dissection.
###end p 64
###begin title 65
References
###end title 65
###begin article-title 66
Metabolism and cancer: the circadian clock connection.
###end article-title 66
###begin article-title 67
Interplay of circadian clocks and metabolic rhythms.
###end article-title 67
###begin article-title 68
Post-translational modifications regulate the ticking of the circadian clock.
###end article-title 68
###begin article-title 69
Mitogen-activated protein kinase phosphorylates and negatively regulates basic helix-loop-helix-PAS transcription factor BMAL1.
###end article-title 69
###begin article-title 70
CK2alpha phosphorylates BMAL1 to regulate the mammalian clock.
###end article-title 70
###begin article-title 71
The circadian regulatory proteins BMAL1 and cryptochromes are substrates of casein kinase Iepsilon.
###end article-title 71
###begin article-title 72
CLOCK-mediated acetylation of BMAL1 controls circadian function.
###end article-title 72
###begin article-title 73
Circadian clock control by SUMOylation of BMAL1.
###end article-title 73
###begin article-title 74
Dual modification of BMAL1 by SUMO2/3 and ubiquitin promotes circadian activation of the CLOCK/BMAL1 complex.
###end article-title 74
###begin article-title 75
BMAL1 shuttling controls transactivation and degradation of the CLOCK/BMAL1 heterodimer.
###end article-title 75
###begin article-title 76
GSK-3: tricks of the trade for a multi-tasking kinase.
###end article-title 76
###begin article-title 77
Judging a protein by more than its name: GSK-3.
###end article-title 77
###begin article-title 78
Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes.
###end article-title 78
###begin article-title 79
Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy.
###end article-title 79
###begin article-title 80
The glamour and gloom of glycogen synthase kinase-3.
###end article-title 80
###begin article-title 81
###xml 57 67 <span type="species:ncbi:7227">Drosophila</span>
A role for the segment polarity gene shaggy/GSK-3 in the Drosophila circadian clock.
###end article-title 81
###begin article-title 82
###xml 77 87 <span type="species:ncbi:7227">Drosophila</span>
The double-time protein kinase regulates the subcellular localization of the Drosophila clock protein period.
###end article-title 82
###begin article-title 83
A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta.
###end article-title 83
###begin article-title 84
A role for glycogen synthase kinase-3beta in the mammalian circadian clock.
###end article-title 84
###begin article-title 85
Ser-557-phosphorylated mCRY2 is degraded upon synergistic phosphorylation by glycogen synthase kinase-3 beta.
###end article-title 85
###begin article-title 86
Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock.
###end article-title 86
###begin article-title 87
Nucleocytoplasmic shuttling and mCRY-dependent inhibition of ubiquitylation of the mPER2 clock protein.
###end article-title 87
###begin article-title 88
After hours keeps clock researchers CRYing Overtime.
###end article-title 88
###begin article-title 89
The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell.
###end article-title 89
###begin article-title 90
SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock.
###end article-title 90
###begin article-title 91
Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling.
###end article-title 91
###begin article-title 92
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo.
###end article-title 92
###begin article-title 93
How the ubiquitin-proteasome system controls transcription.
###end article-title 93
###begin article-title 94
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade.
###end article-title 94
###begin article-title 95
Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1.
###end article-title 95
###begin article-title 96
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors.
###end article-title 96
###begin article-title 97
Mop3 is an essential component of the master circadian pacemaker in mammals.
###end article-title 97
###begin article-title 98
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock.
###end article-title 98
###begin article-title 99
Brain and muscle Arnt-like protein-1 (BMAL1), a component of the molecular clock, regulates adipogenesis.
###end article-title 99
###begin article-title 100
BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis.
###end article-title 100
###begin article-title 101
Physiological significance of a peripheral tissue circadian clock.
###end article-title 101
###begin article-title 102
BMAL1-dependent circadian oscillation of nuclear CLOCK: posttranslational events induced by dimerization of transcriptional activators of the mammalian clock system.
###end article-title 102
###begin article-title 103
Quantitative proteomics reveals a dynamic interactome and phase-specific phosphorylation in the Neurospora circadian clock.
###end article-title 103
###begin article-title 104
###xml 70 75 <span type="species:ncbi:9606">human</span>
Differential effects of PER2 phosphorylation: molecular basis for the human familial advanced sleep phase syndrome (FASPS).
###end article-title 104
###begin article-title 105
A serine cluster mediates BMAL1-dependent CLOCK phosphorylation and degradation.
###end article-title 105
###begin article-title 106
The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator.
###end article-title 106
###begin article-title 107
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Dissecting the functions of the mammalian clock protein BMAL1 by tissue-specific rescue in mice.
###end article-title 107
###begin article-title 108
The age of crosstalk: phosphorylation, ubiquitination, and beyond.
###end article-title 108
###begin article-title 109
Regulation of transcriptional activation domain function by ubiquitin.
###end article-title 109
###begin article-title 110
Posttranslational mechanisms regulate the mammalian circadian clock.
###end article-title 110
###begin p 111
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 111
###begin p 112
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: S.S. was partially supported by a post-doctoral fellowship from American Heart Association, Western States Affiliates. L.Z. was supported by an American-Italian Cancer Foundation post-doctoral fellowship. Work in the laboratories is supported by the National Institute of Health (R01-DA024689; R01-GM081634-01) and the Institut National de la Sante et de la Recherche Medicale (U904) (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 112

